AstraZeneca Pharmaceuticals LP v. McClain
AstraZeneca Pharmaceuticals LP |
Alan McClain |
4:2024cv00268 |
March 25, 2024 |
US District Court for the Eastern District of Arkansas |
Brian S Miller |
Constitutional - State Statute |
28 U.S.C. ยง 2201 Declaratory Judgement |
None |
Docket Report
This docket was last retrieved on March 25, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 3 NOTICE of Appearance by Kendall Booth Rand on behalf of Alan McClain (Rand, Kendall) |
Filing 2 Corporate Disclosure Statement (Rule 7.1) by AstraZeneca Pharmaceuticals LP. (csf) |
Filing 1 COMPLAINT for Declaratory and Injunctive Relief against Alan McClain filed by AstraZeneca Pharmaceuticals LP. (Fee $405. Receipt Number LIT5791.) Summons issued and returned to counsel. (Attachments: #1 Civil Cover Sheet)(csf) (Docket text modified on 3/25/2024 to correct the description of the document filed) (jak) |
NOTICE OF DOCKET CORRECTION re #1 Complaint. CORRECTION: The docket text was modified to correct the description of the document filed as "COMPLAINT for Declaratory and Injunctive Relief against Alan McClain filed by AstraZeneca Pharmaceuticals LP" as marked on the document. (jak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Arkansas Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.